| 1NDMA |
|---|
| 2NDEA |
search
Applications
NDMA and NDEA by GC/MS on a ZB-624Plus (Valsartan Tablet #1)
25327
Separation Mode: Improved Performance
Improved Performance
ZB-624plus
GC
Alkylating Agents
Pharmaceutical/Biopharmaceutical
Organic Chemical
Chemical Compound
Analytes
Details
GC Conditions (App ID: 25327)
Column: |
Part No: |
Phase Name: ZB-624plus |
System: Shimadzu GC System Shimadzu GC System |
Sample Notes: 500 mg Valsartan tablet (#1) analyzed and found to contain 5 ppb NDMA and 264 ppb NDEA Tablet was crushed and mixed in 1 mL of DMSO in a 20 mL headspace vial. |
Similar Applications
search
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.